Peer Review History

Original SubmissionMarch 9, 2022
Decision Letter - Yajing Wang, Editor

PONE-D-22-07130Dynamic physical examination indicators of cardiovascular health: A single-center study in Shanghai, ChinaPLOS ONE

Dear Dr. Yu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 15 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Yajing Wang

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors of the present manuscript highlight the importance of the full utilization of physical examination databases in China. They performed a prospective study including 14,044 participants and a three-year follow-up. Overall, this manuscript is well prepared and organized. My major concerns are as listed as below:

1. The definition of healthy people is unclear. People with routine physical examinations are not qualified enough to be healthy. Accordingly, for the inclusion criterion, the authors should clearly mention that all the participants are initially without systemic diseases, especially are free of cardiovascular disease (CVD). If they didn’t strictly follow this criterion, they better reanalyze data (excluding individuals with diseases) or use a more accurate word to describe participants instead of “healthy individuals”.

2. They didn’t mention whether these participants developed new-onset CVD or with CVD-targeted medication treatments during the three-year period, which has a strong effect on these indicators they collected. Ignoring these factors may result in incorrect conclusions. If all the participants were finally free of CVD, in the exclusion criterion section, they should mention people developing CVD are excluded; Otherwise, they better analyze the percentage of people developing CVD and with CVD-targeted medication treatments. If these data are unavailable to the authors, they better explain them in the discussion part.

3. The age-based analysis of blood pressure and lipids levels are kinds of inconsistent with the major publications, and the references the authors referred to for this part are not convinced enough. The authors better do a deeper discussion about the potential factors or increase the inclusion criterion to get a more accurate conclusion.

Reviewer #2: 1. Incremental findings: Previous studies have reported that increasing SBP, DBP, BMI, and TG, LDL-C, and Glu levels and decreasing HDL-C levels increases the risk of CVDs. Combined with the results of this study, the SBP, DBP, BMI, and TG, LDL-C, and Glu levels of men were higher than those of women for each year, while their HDL-C levels were lower than those of women. Therefore, these findings will provide explicit evidence for early identification and timely intervention in high-risk male populations based on the changing trend of the indicators mentioned above.

2. Dietary habits, exercise habits, and sleep characteristics were not enrolled.

3. I suggest do analysis between male and female group.

4. There is Meta-analyzed publish related to this paper, suggest add to discussion.

5. The manuscript, particularly the results, need to be better organized to improve the readability.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: plos-Wenya Yu.docx
Revision 1

RESPONSE TO REVIEWERS

Reviewer #1

The authors of the present manuscript highlight the importance of the full utilization of physical examination databases in China. They performed a prospective study including 14,044 participants and a three-year follow-up. Overall, this manuscript is well prepared and organized. My major concerns are as listed as below:

Q1. The definition of healthy people is unclear. People with routine physical examinations are not qualified enough to be healthy. Accordingly, for the inclusion criterion, the authors should clearly mention that all the participants are initially without systemic diseases, especially are free of cardiovascular disease (CVD). If they didn’t strictly follow this criterion, they better reanalyze data (excluding individuals with diseases) or use a more accurate word to describe participants instead of “healthy individuals”.

Response: Thank you for your valuable comments. We apologize for the unclear statement. To properly describe healthy individuals in our study and the reasons for inclusion and exclusion, we have defined the term and added explanations in the methods section.

Page 4; lines 72-76

To ensure the three-year continuity of the data of healthy people, details of physical examinations in this study were obtained from the annual physical examinations of the enrolled participants, which were provided by the participants’ employers. Healthy individuals in this study refers to the participants that initially has no systemic diseases, and were particularly free of CVDs.

Page 4; lines 82-84

The exclusion criteria were physical examination records of only one or two years and incomplete indicator results; as well as participants who developed CVDs between 2018 and 2020.

Q2. They didn’t mention whether these participants developed new-onset CVD or with CVD-targeted medication treatments during the three-year period, which has a strong effect on these indicators they collected. Ignoring these factors may result in incorrect conclusions. If all the participants were finally free of CVD, in the exclusion criterion section, they should mention people developing CVD are excluded; Otherwise, they better analyze the percentage of people developing CVD and with CVD-targeted medication treatments. If these data are unavailable to the authors, they better explain them in the discussion part.

Response: All the participants were finally free of CVDs, which has been added as an exclusion criterion in the Methods section.

Page 4; lines 82-84

The exclusion criteria were physical examination records of only one or two years and incomplete indicator results; as well as participants who developed CVDs between 2018 and 2020.

Q3. The age-based analysis of blood pressure and lipids levels are kinds of inconsistent with the major publications, and the references the authors referred to for this part are not convinced enough. The authors better do a deeper discussion about the potential factors or increase the inclusion criterion to get a more accurate conclusion.

Response: Thank you for your comment. The in-depth discussion about age-based analysis of blood pressure and lipids levels has been added, and more related references supporting our findings have been cited. Please see detailed revisions on pages 17-18; lines 189-216.

#Reviewer 2

The study by Kuang et al. attempted to analyze dynamic physical examination indicators for cardiovascular health to provide evidence for the precise prevention and control of cardiovascular diseases in the primary prevention domain among healthy individuals with different demographic characteristics in Shanghai. and if so, to provide more accurate evidence for health providers to prevent and control CVDs in healthy individuals, especially in high-risk populations.

The authors reported that The CVH status of healthy individuals in Shanghai demonstrated a decreasing trend from 2018 to 2020. Strengthening the primary prevention of CVD-related physical examination indicators among high-risk individuals, especially for the dynamic change in trends of SBP, DBP, BMI, and levels of TG, LDL-C, and Glu in men, as well as the change in trend of TC levels in women, is necessary. Moreover, healthcare providers should closely monitor the CVH indicators in people aged 50–69 years, as these indicators are more sensitive to controlling the prevalence of CVDs in this population.

Q1. Incremental findings: Previous studies have reported that increasing SBP, DBP, BMI, and TG, LDL-C, and Glu levels and decreasing HDL-C levels increases the risk of CVDs. Combined with the results of this study, the SBP, DBP, BMI, and TG, LDL-C, and Glu levels of men were higher than those of women for each year, while their HDL-C levels were lower than those of women. Therefore, these findings will provide explicit evidence for early identification and timely intervention in high-risk male populations based on the changing trend of the indicators mentioned above.

Response: Thank you for your kind comments.

Q2. Dietary habits, exercise habits, and sleep characteristics were not enrolled.

Response: Thank you for your comment. Due to the data availability, it is difficult to obtain these characteristics, and thus these were presented as a limitation of this study.

Page 18; lines 217-222

This study has some limitations. First, this study was single-centered owing to data accessibility, which may have led to some constraints in the representation and feasibility of our findings. Second, the data in this study only included indicators from physical examination items; thus, other indicators that are significant for the control and prevention of CVDs were not included. Third, the data in this study were only laboratory testing indicators, and other factors such as dietary habits, exercise habits, and sleep characteristics were not analyzed.

Q3. I suggest do analysis between male and female group.

Response: Thank you for your suggestion. The variance analysis results of repeated measurements based on different sexes from 2018 to 2020 were conducted. Please see the detailed results on pages 7-8; lines 117-128, and Table 3.

Q4. There is Meta-analyzed publish related to this paper, suggest add to discussion.

Response: Thank you for your suggestion. We have cited additional references supporting and interpreting our findings combined your valuable and other Reviewer’s comments. Please see detailed revisions in the Discussion section.

Q5. The manuscript, particularly the results, need to be better organized to improve the readability.

Response: Thank you for your comment. We revised the part of results to improve the readability. Please see the revisions in the Results section.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Yajing Wang, Editor

Dynamic physical examination indicators of cardiovascular health: A single-center study in Shanghai, China

PONE-D-22-07130R1

Dear Dr. Yu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yajing Wang

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript looks fine now, just with one minor error:

In Page 4; lines 74-76,

“Healthy individuals in this study refers to the participants that initially has no systemic diseases, and were particularly free of CVDs.” is supposed to be “Healthy individuals in this study refers to the participants that initially have no systemic diseases, and were particularly free of CVDs.”

Reviewer #2: Incremental findings: Previous studies have reported that increasing SBP, DBP, BMI, and TG, LDL-C, and Glu levels and decreasing HDL-C levels increases the risk of CVDs. Combined with the results of this study, the SBP, DBP, BMI, and TG, LDL-C, and Glu levels of men were higher than those of women for each year, while their HDL-C levels were lower than those of women. Therefore, these findings will provide explicit evidence for early identification and timely intervention in high-risk male populations based on the changing trend of the indicators mentioned above. The manuscript readability was improved.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Fujie Zhao

Reviewer #2: No

Attachments
Attachment
Submitted filename: plos-Wenya Yu.docx
Formally Accepted
Acceptance Letter - Yajing Wang, Editor

PONE-D-22-07130R1

Dynamic physical examination indicators of cardiovascular health: A single-center study in Shanghai, China

Dear Dr. Yu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yajing Wang

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .